Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Icanbelimod
2. 1514888-56-2
3. S1p-receptor-agonist-1
4. Icanbelimod [inn]
5. Yun88562
6. Ar507630
7. Ar-507630
8. J055n05pgq
9. 1-[[2-fluoro-4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]azetidine-3-carboxylic Acid
10. 1-((2-fluoro-4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methyl)-3-azetidine Carboxylic Acid
11. 1-[[2-fluoranyl-4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]methyl]azetidine-3-carboxylic Acid
12. 3-azetidinecarboxylic Acid, 1-((2-fluoro-4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)methyl)-
13. 1-((2-fluoro-4-(5-(4-(2-methylpropyl)phenyl)-1,2,4- Oxadiazol-3-yl)phenyl)methyl)azetidine-3-carboxylic Acid
14. 1-[(2-fluoro-4-{5-[4-(2-methylpropyl)phenyl]-1,2,4- Oxadiazol-3-yl}phenyl)methyl]azetidine-3-carboxylic Acid
15. 7i4
16. S1p-agonist-1
17. Unii-j055n05pgq
18. Chembl4097139
19. Schembl16591177
20. Gtpl12098
21. Bcp31070
22. Ex-a2486
23. Akos037515529
24. Cs-6254
25. Compound 2 [wo2015039587a1]
26. Ms-27049
27. Hy-101265
28. F85514
29. 1-(2-fluoro-4-(5-(4-isobutylphenyl)-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylic Acid
| Molecular Weight | 409.5 g/mol |
|---|---|
| Molecular Formula | C23H24FN3O3 |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 79.5 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 578 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A S1p receptor agonist 1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of S1p receptor agonist 1, including repackagers and relabelers. The FDA regulates S1p receptor agonist 1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. S1p receptor agonist 1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A S1p receptor agonist 1 supplier is an individual or a company that provides S1p receptor agonist 1 active pharmaceutical ingredient (API) or S1p receptor agonist 1 finished formulations upon request. The S1p receptor agonist 1 suppliers may include S1p receptor agonist 1 API manufacturers, exporters, distributors and traders.
S1p receptor agonist 1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of S1p receptor agonist 1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right S1p receptor agonist 1 GMP manufacturer or S1p receptor agonist 1 GMP API supplier for your needs.
A S1p receptor agonist 1 CoA (Certificate of Analysis) is a formal document that attests to S1p receptor agonist 1's compliance with S1p receptor agonist 1 specifications and serves as a tool for batch-level quality control.
S1p receptor agonist 1 CoA mostly includes findings from lab analyses of a specific batch. For each S1p receptor agonist 1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
S1p receptor agonist 1 may be tested according to a variety of international standards, such as European Pharmacopoeia (S1p receptor agonist 1 EP), S1p receptor agonist 1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (S1p receptor agonist 1 USP).
LOOKING FOR A SUPPLIER?
